Skip to main content
. 2011 Feb 11;88(2):150–161. doi: 10.1016/j.ajhg.2011.01.003

Table 1.

Association Results

Population Origin (in Collaboration with) Genotyped SNPs (Major/Minor allele) Cleft Type Number of Individuals (T = 7597) Number of Affected Individuals Associated SNP (Associated Allele) Familial History TDT p Value rs1149795 TDT p Value rs3827730 Relative risk of CPO Conferred by TT Genotype of rs3827730; p value
Belgium rs6588392 (C/G), rs11205768 (T/C), rs17387761(G/A), rs3827730 (T/C) mixed 1072 421 rs3827730 (T) S N/A 0.004
CPO 325 126 rs3827730 (T) S N/A 0.001 2.72 (1.49-4.98); p = 0.001
CL 227 94 none S N/A 0.23
CLP 520 202 none S N/A 0.45
CL/P 747 296 none S N/A 0.15
European descent- Iowa, USA (J. Murray) rs11205760 (C/T), rs1149795 (T/C), rs3827730 (C/T), rs2784143 (C/T), rs2455636 (G/A) mixed 981 350 rs1149795 (C) F + S 0.006 0.16
CPO 246 90 rs1149795 (C) F + S 0.02 0.34 1.23 (0.6–2.53); p = 0.569
CL 275 91 none F + S 0.67 0.78
CLP 412 146 none F + S 0.61 0.34
CL/P 42 22 none F + S 0.1 0.65
European descent- Texas, USA (J. Hecht) rs3827730 (T/C) CL/P 499 N/A rs3827730 (T) F + S N/A 0.38
Mexican Hispanics- Texas, USA (J. Hecht) rs3827730 (T/C) CL/P 177 N/A rs3827730 (T) F + S N/A 0.14
Philippines (J. Murray) rs11205760 (C/T), rs1149795 (T/C), rs3827730 (T/C), rs2784143 (C/T), rs2455636 (G/A) mixed 2511 570 none F 0.73 0.62
CPO 22 4 none F NI 0.52
CL 429 98 none F 1 0.93
CLP 1203 246 none F 0.86 0.78
CL/P 823 212 none F 0.51 0.29
Germany (E. Mangold) rs11205760 (C/T), rs17387761 (G/A), rs11587909 (C/T), rs17382596 (T/G), rs3827730 (T/C) mixed 1514 679 none N/A N/A 0.16
CPO 242 99 none N/A N/A 0.78 1.17 (0.63-2.17); p = 0.624
CL 225 99 none N/A N/A 1
CLP 1047 481 none N/A N/A 0.12
CL/P 1272 580 none N/A N/A 0.16
Eurocran and Italcleft: IT, NL, UK, HU, SL, ET, SK, and BU (M. Rubini) rs1149795 (T/C), rs3827730 (C/T), rs17382596 (T/G) CPO 843 281 rs3827730 (T) S 0.67 0.007 1.38 (1.02-1.87); p = 0.036
NL CPO 165 55 none S N/A 0.42 1.02 (0.51-2.05); p = 0.955
IT CPO 183 61 rs3827730 (T) S N/A 0.02 2.04 (1.06-3.96); p = 0.034
UK CPO 201 67 none S N/A 0.43 1.44 (0.77-2.70); p = 0.252
Eurocran Western Europe (NL + IT + UK) CPO 549 183 rs3827730 (T) S N/A 0.03 1.43 (0.98- 2.08); p = 0.064
Eurocran Eastern Europe (HU, SL, ET, SK, BU) CPO 294 98 none S N/A 0.09 1.38 (0.82-2.30); p = 0.224
Belgium + Germany + Eurocran and Italcleft rs3827730 (C/T) CPO 1410 506 rs3827730 (T) S+N/A N/A 0.0007 1.51 (1.18-1.93); p = 0.001
Belgium + Germany + Eurocran and Italcleft + Iowa rs3827730 (C/T) CPO 1656 596 rs3827730 (T) F+S N/A 0.0003 1.47 (1.17-1.86); p = 0.001

TDT was done with the FBAT program for all populations except the European-descent cohort from Texas (APL). Notations are as follows: mixed, all cleft types together (CPO + CL + CLP); CPO, cleft palate only; CL, cleft lip; CLP, cleft lip and palate; CL/P, ceft lip with or without cleft palate; F, familial; S, sporadic; N/A, not available; NI, not informative; T, total; IT, Italy; NL, The Nerherlands; UK, The United Kingdom; HU Hungary; SL Slovenia; ET, Estonia; SK, Slovakia; and BU, Bulgaria. Note that in the CPO cohort from Belgium, 38 patients had isolated PRS (CPO + retrognatia), all others had CPO.